Current Assets
Available-for-Sale Debt Securities - Fair Value by Maturity
Moderna Available-for-Sale Debt Securities - Fair Value by Maturity increased by 0.1% to $5.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.1%, from $6.77B to $5.55B. Over 5 years (FY 2020 to FY 2025), Available-for-Sale Debt Securities - Fair Value by Maturity shows an upward trend with a 16.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 1, 2026
How to read this metric
A shift toward longer maturities may indicate a search for higher yields, while shorter maturities suggest a defensive posture against rising interest rates.
Detailed definition
This metric provides a breakdown of the fair value of available-for-sale debt securities categorized by their contractua...
Peer comparison
Standard disclosure in the investment securities note for all banks.
Metric ID:
afs_debt_securities_fair_value_by_maturityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.59B | $9.80B | $10.72B | $14.24B | $15.19B | $13.98B | $15.02B | $12.92B | $10.76B | $9.91B | $10.37B | $10.11B | $8.34B | $7.56B | $7.59B | $6.77B | $6.23B | $5.52B | $5.54B | $5.55B |
| QoQ Change | — | +48.6% | +9.4% | +32.8% | +6.7% | -8.0% | +7.4% | -13.9% | -16.7% | -7.9% | +4.6% | -2.5% | -17.5% | -9.3% | +0.4% | -10.8% | -8.0% | -11.4% | +0.5% | +0.1% |
| YoY Change | — | — | — | — | +130.3% | +42.6% | +40.0% | -9.2% | -29.1% | -29.1% | -30.9% | -21.8% | -22.5% | -23.8% | -26.8% | -33.0% | -25.3% | -27.0% | -27.0% | -18.1% |
Range$5.52B – $15.19B
CAGR-3.6%
Avg YoY Growth-6.9%
Median YoY Growth-24.5%
Current Streak2 quarters growth
Available-for-Sale Debt Securities - Fair Value by Maturity at Other Companies
Frequently Asked Questions
- What is Moderna's available-for-sale debt securities - fair value by maturity?
- Moderna (MRNA) reported available-for-sale debt securities - fair value by maturity of $5.55B in Q1 2026.
- How has Moderna's available-for-sale debt securities - fair value by maturity changed year-over-year?
- Moderna's available-for-sale debt securities - fair value by maturity decreased by 18.1% year-over-year, from $6.77B to $5.55B.
- What is the long-term trend for Moderna's available-for-sale debt securities - fair value by maturity?
- Over 5 years (2020 to 2025), Moderna's available-for-sale debt securities - fair value by maturity has grown at a 16.1% compound annual growth rate (CAGR), from $2.62B to $5.54B.
- What does available-for-sale debt securities - fair value by maturity mean?
- The fair value of investment debt securities organized by when they are scheduled to mature.